Five things for pharma marketers to know: Monday, April 10, 2017
Gilead receives approval to market Harvoni, Sovaldi to adolescents; OncoMed ends mid-stage trials for pancreatic cancer drug; researchers use facial recognition software to diagnose
Artificial Intelligence
Monday at SXSW: That’s a wrap
SXSW’s health track finally got a seat at the big-kids table.
Five things for pharma marketers to know: Monday, March 6, 2017
Gilead exec blames PBMs for high drug prices; Google uses AI to detect signs of breast cancer; Sanofi and Regeneron drug effective in treating eczema
Why healthbots may eat search ads and mobile apps
The internet strongly agrees there’s an artificial intelligence revolution going on, and it’s come to pharma marketing.
Pharma adopts data-science culture in move toward AI
Data scientists are a new kind of insight and analytics professional showing up in the biopharma ranks.
